The effect of therapeutic human serum drops on corneal stromal wound-healing activity

Current Eye Research

Volumn 33, Issue 8, 2008, Pages 641-652

  Watson, Stephanie L ^a,b,c   Secker, Genevieve A ^b   Daniels, Julie T ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Cornea; Fibroblast; Serum; Therapeutic; Wound healing

Indexed keywords

COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; HYDROXYPROPYLMETHYLCELLULOSE; INTERSTITIAL COLLAGENASE; TETRAZOLIUM;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CORNEA INJURY; CORNEA STROMA; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SERUM; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CORNEAL STROMA; DIPEPTIDES; FIBROBLASTS; HUMANS; KERATIN-12; KERATIN-3; MATRIX METALLOPROTEINASES; MICROSCOPY, CONFOCAL; OPHTHALMIC SOLUTIONS; PROTEASE INHIBITORS; SERUM; VIMENTIN; WOUND HEALING;

EID: 49549092015     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802254790     Document Type: Article

References (65)

1. Daniels JT, Khaw PT. Temporal stimulation of corneal fibroblast wound-healing activity by differentiating epithelium in vitro. Invest Ophthalmol Vis Sci. 2000;41(12):3754-3762.
2. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18(3):293-309.
3. Nakamura K. Interaction between injured corneal epithelial cells and stromal cells. Cornea. 2003;22(7):S35-S47.
4. Wilson SE, Kim WJ. Keratocyte apoptosis: Implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39(2):220-226.
5. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, Dean NM, et al. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: A role for connective tissue growth factor in contractile scarring. Am J Pathol. 2003;163(5):2043-2052.
6. Poon AC, Geerling G, Dart JKG, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.
7. Esquenazi S, He J, Bazan H, Bazan N. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea. 2005;24(8):992-997.
8. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142(2):207-211.
9. Mukerji N, Sinha R, Vajpayee RB. Role of autologous serum in persistent epithelial defects. Br J Ophthalmol. 2002;86(7):832.
10. Bonini S, Lambiase A, Rama P, Caprioglio G. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347-1352.
11. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106:1984-1989.
12. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111(6):1115-1120.
13. Ferreira DS, Kruse FE, Seitz B. Autologous serum for otherwise therapy-resistant corneal epithelial defects - Prospective report on the first 70 eyes. Klin Monatsbl Augenheilkd. 2001;218(11):720-726.
14. Nakamura T, Ang LP, Rigby H, Sekiyama E, Inatomi T, Sotozono C, et al. The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens-Johnson syndrome. Invest Ophthalmol Vis Sci. 2006;47(3):909-916.
15. Ang LP, Nakamura T, Inatomi T, Sotozono C, Koizumi N, Yokoi N, et al. Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease. Arch Ophthalmol. 2006;124(11):1543-1551.
16. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40(4):113-122.
17. Cher I. Blink-related microtrauma: When the ocular surface harms itself. Clin Exp Ophthalmol. 2003;31(3):183-190.
18. Schultz GS, Davis JB, Eiferman RA. Growth factors and corneal epithelium. Cornea. 1988;7(2):96-101.
19. Schultz GS, Chegini N, Grant M, Khaw PT, MacKay S. Effects of growth factors on corneal wound healing. Acta Ophthalmol Suppl. 1992;70(202):60-66.
20. Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32(3):149-170.
21. Friedenwald J. Some problems in the diagnosis and treatment of glaucoma. Am J Ophthalmol. 1950;33(10):1523-1538.
22. Smith MF, Magauran RGI, Betchkal J, Doyle JW. Treatment of postfiltration bleb leaks with autologous blood. Ophthalmology. 1995;102(6):868-871.
23. Wise JB. Treatment of chronic postfiltration hypotony by intrableb injection of autologous blood. Arch Ophthalmol. 1993;111(6):827-830.
24. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18(4):529-551.
25. Jester JV, Huang J, Petroll WM, Cavanagh HD. TGF-beta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGF-beta, PDGF, and integrin signaling. Exp Eye Res. 2002;75(6):645-657.
26. Netto MV, Mohan RR, Ambrosio RJ, Hutcheon AEK, Zieske JD, Wilson SE. Wound healing in the cornea: A review of refractive surgery complications and new prospects for therapy. Cornea. 2005;24(5):509-522.
27. Jester JV, Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003;77(5):581-593.
28. Tarpila E, Ghassemifar RM, Franzen LE. Fibroblast movements during contraction of collagen lattices - A quantitative study using a new three-dimensional time-lapse technique with phase-contrast laser scanning microscopy. In Vitro Cell Dev Biol Anim. 1998;34(8):640-645.
29. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol. 2002;3(5):349-363.
30. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, et al. Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci. 2003;44(3):1104-1110.
31. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol. 2002;47(3):239-256.
32. Daniels JT, Geerling G, Alexander RA, Murphy G, Khaw PT, Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res. 2003;77(6):653-664.
33. Espana EM, Romano AC, Kawakita T, Di PM, Smiddy R, Tseng SC. Novel enzymatic isolation of an entire viable human limbal epithelial sheet. Invest Ophthalmol Vis Sci. 2003;44(10):4275-4281.
34. Occleston NL, Alexander RA, Mazure A, Larkin G, Khaw PT. Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction. Invest Ophthalmol Vis Sci. 1994;35(10):3681-3690.
35. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA. 1979;76(3):1274-1278.
36. Ehrlich HP, Rajaratnam JB. Cell locomotion forces versus cell contraction forces for collagen lattice contraction: An in vitro model of wound contraction. Tissue Cell. 1990;22(4):407-417.
37. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol. 1999;154(3):871-882.
38. Varani J, Hattori Y, Chi Y, Schmidt T, Perone P, Zeigler ME, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: Comparison with normal skin. Br J Cancer. 2000;82(3):657-665.
39. Elder MJ, Hiscott P, Dart JK. Intermediate filament expression by normal and diseased human corneal epithelium. Hum Pathol. 1997;28(12):1348-1354.
40. Daniels JT, Harris IR, Kearney JN, Ingham E. Calcium: A crucial consideration in serum-free keratinocyte culture. Exp Dermatol. 1995;4(1):183-191.
41. Geerling G, Daniels JT, Dart JK, Cree IA, Khaw PT. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2001;42(5):948-956.
42. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea. 1996;15(2):120-128.
43. Versura P, Maltarello MC, Stecher F, Caramazza R, Laschi R. Dry eye before and after therapy with hydroxypropyl methylcellulose. Ultrastructural and cytochemical study in 20 patients. Ophthalmologica. 1989;198(3):152-162.
44. Adams J, Wilcox MJ, Trousdale MD, Chien DS, Shimizu RW. Morphologic and physiologic effects of artificial tear formulations on corneal epithelial derived cells. Cornea. 1992;11(3):234-241.
45. Grene RB, Lankston P, Mordaunt J, Harrold M, Gwon A, Jones R. Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca. Cornea. 1992;11(4):294-301.
46. Nelson JD, Drake MM, Brewer Jr. JT, Tuley M. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca. Adv Exp Med Biol. 1994;350:453-457.
47. Daniels JT, Limb GA, Saarialho-Kere U, Murphy G, Khaw PT. Human corneal epithelial cells require MMP-1 for HGF-mediated migration on collagen I. Invest Ophthalmol Vis Sci. 2003;44(3):1048-1055.
48. Medina A, Scott P, Ghahary A, Tredget E. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil. 2005;26(4):306-319.
49. Ma DH, Zhang F, Shi W, Yao JY, Hsiao CH, Wu HC, et al. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res. 2003;35(4):199-207.
50. Ohji M, SundarRaj N, Thoft RA. Transforming growth factor-beta stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro. Curr Eye Res. 1993;12(8):703-709.
51. Beales MP, Funderburgh JL, Jester JV, Hassell JR. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: Maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40(8):1658-1663.
52. Hibino T, Wada Y, Mishima H, Otori T. The effect of corneal epithelial cells on the collagen gel contraction by keratocytes. Jpn J Ophthalmol. 1998;42(3):174-179.
53. Wilson SE, Netto M, Ambrosio Jr. R. Corneal cells: Chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol. 2003;136(3):530-536.
54. Wilson SE, He YG, Weng J, Li Q, McDowall AW, Vital M, et al. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 1996;62(4):325-327.
55. Wilson SE, Mohan RR, Mohan RR, Ambrosio Jr. R, Hong J, Lee J. The corneal wound-healing response: Cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20(5):625-637.
56. Lim M, Goldstein MH, Tuli S, Schultz GS. Growth factor, cytokine, and protease interactions during corneal wound healing. Ocul Surf. 2003;1(2):53-65.
57. Wu KY, Wang HZ, Hong SJ. Effects of antibiotics and corticosteroid eyedrops on cellular proliferation in cultured human corneal keratocytes. Kaohsiung J Med Sci. 2006;22(8):385-389.
58. Foreman DM, Pancholi S, Jarvis-Evans J, McLeod D, Boulton ME. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res. 1996;62:555-564.
59. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transpl. 2003;31(7):579-583.
60. Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88(11):1467-1474.
61. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88(5):647-652.
62. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20(8):802-806.
63. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
64. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999;83:390-395.
65. Fox RI, Chan R, Michelson J, Belmont J, Michelson P. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.